C9orf72 リピート・エクスパンションはヒトのiPSC由来マイクログリアの代謝機能障害を誘発し,グリアルニューロン交響を調節する
Marika Mearelli1,2, Insa Hirschberg1,2, Christin Weissleder3
1Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Glia
|September 1, 2025
まとめ
C9orf72変異はアミオトロフィック横筋硬化症 (ALS) の細胞代謝を乱します. マイクログリアは糖分分解活動と酸化ストレスが増加し,モーターニューロンの脆弱性に影響します.
科学分野:
- 神経科学
- 遺伝学
- 細胞生物学
背景:
- C9orf72ヘクサヌクレオチドの再発は,アミオトロフィック横筋硬化症 (ALS) とフロントテンポラル認知症の主要な遺伝的原因です.
- この変異の細胞タイプ特有の代謝および免疫経路の効果は十分に理解されていません.
研究 の 目的:
- C9orf72患者の誘発性多能幹細胞 (iPSC) 派生ニューロン,アストロサイト,およびマイクログリアにおける細胞タイプ特有の代謝変化を調査する.
- 基礎的および炎症的条件下での代謝変化とその細胞間通信への影響を調べる.
主な方法:
- C9orf72患者と同位体対照群の iPSC 派生モーターニューロン,アストロサイト,およびマイクログリアを使用した.
- 基礎および炎症条件下で単細胞代謝分析を行った.
- 細胞間効果をモデル化するために,ヒトのiPSC (モーターニューロン,アストロサイト,マイクログリア) から派生したトリカルチャーシステムを開発した.
主要な成果:
- C9orf72マイクログリアは,ミトコンドリアの呼吸機能が低下したC9orf72モーターニューロンとは異なり,高解糖活性,酸化ストレス,および代謝酵素のアップレギュレーションを示します.
- 炎症刺激はC9orf72マイクログリアの代謝障害を悪化させる.
- アストロサイトにおけるマイクログリア駆動の代謝再プログラミングは,トリカルチャーシステムにおけるモーターニューロンの脆弱性に寄与する.
結論:
- マイクログリアは,ALSの病原性における代謝失調と細胞間クロストラックに中心的な役割を果たします.
- 免疫細胞の代謝経路を標的にすることは,ALSの潜在的な治療戦略です.
関連する概念動画
Pleiotropy
31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28


